A major adverse effect of glucocorticoid treatment is significant bone loss, which is most pronounced in the first 3 to 6 months of use.
The use of bone-specific drugs, such as those for osteoporosis treatment, is linked to an increased risk for osteonecrosis of sites other than the jaw.
Fracture and mortality risk are not significantly different between periods of ongoing bisphosphonate treatment and bisphosphonate holidays.
High-intensity dynamic resistance training helps to maintain lumbar spine bone mineral density and increase skeletal muscle mass index in older men.
In this case report, the researchers identified a novel mutation associated with a diagnosis of hypophosphatemic kidney stones and osteoporosis.
Organic nitrates did not affect bone density or turnover in postmenopausal women with osteopenia in a randomized controlled trial.
A coalition of experts representing multiple medical societies issued guidance on the management of osteoporosis during the COVID-19 pandemic.
Gains in bone mineral density associated with bisphosphonate treatment in patients with osteoporosis are reduced with decreasing kidney function.
Postmenopausal women with low income and less education are more likely to have coexistence of metabolic syndrome and osteoporosis.
There are changes in maternal bone mineral density and microarchitecture during pregnancy that exceed the natural age-related changes in women.
Researchers presented the outcomes from a 2-year intervention that included bone-strengthening physical activity and dietary behaviors of children attending after-school programs in the United States.
The improvements in estimated and total body bone mineral density observed with statin treatment may be partly accounted for by their low-density lipoprotein cholesterol-lowering effect.
Want to read more?
Please login or register first to view this content.
Next post in Bone Metabolism